APHA Buy and Sells

House Positions for C:APHA from 20190201 to 20190201

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
79 CIBC	10,718,916	133,772,702	12.48	8,235,576	102,762,138	12.478	2,483,340	-31,010,564
80 National Bank	1,390,292	17,430,147	12.537	1,356,275	16,962,278	12.507	34,017	-467,869
28 BBS	117,252	1,441,642	12.295	84,747	1,058,151	12.486	32,505	-383,491
35 Friedberg	13,500	159,975	11.85	0			13,500	-159,975
14 ITG	21,171	268,849	12.699	10,242	127,913	12.489	10,929	-140,936
19 Desjardins	287,387	3,586,227	12.479	277,408	3,464,150	12.488	9,979	-122,077
70 Manulife	5,343	66,809	12.504	1,315	16,930	12.875	4,028	-49,879
22 Fidelity	2,596	31,749	12.23	250	3,183	12.732	2,346	-28,566
89 Raymond James	6,225	77,974	12.526	4,800	59,500	12.396	1,425	-18,474
6 Infor	6,000	75,295	12.549	5,500	69,155	12.574	500	-6,140
25 Odlum	1,000	12,550	12.55	1,250	15,194	12.155	-250	2,644
48 Laurentian	175	2,143	12.246	1,000	12,360	12.36	-825	10,217
84 Ind Trading	0			1,000	12,150	12.15	-1,000	12,150
56 Edward Jones	1,202	15,091	12.555	2,380	29,680	12.471	-1,178	14,589
68 Leede	7,000	87,212	12.459	8,500	106,029	12.474	-1,500	18,817
15 UBS	100	1,220	12.20	2,500	31,464	12.586	-2,400	30,244
59 PI	0			2,500	31,475	12.59	-2,500	31,475
90 Barclays	0			2,500	29,904	11.962	-2,500	29,904
72 Credit Suisse	0			2,900	35,465	12.229	-2,900	35,465
36 Latimer	15,498	193,713	12.499	19,242	240,417	12.494	-3,744	46,704
76 Industrial Alliance	14,400	178,844	12.42	20,935	258,964	12.37	-6,535	80,120
143 Pershing	27,967	347,045	12.409	40,970	517,019	12.619	-13,003	169,974
74 GMP	7,500	93,630	12.484	21,605	262,583	12.154	-14,105	168,953
101 SG Capital	33,300	420,175	12.618	49,700	618,289	12.44	-16,400	198,114
57 Interactive	15,847	201,141	12.693	32,976	410,443	12.447	-17,129	209,302
88 Credential	223,248	2,789,367	12.494	242,945	3,023,286	12.444	-19,697	233,919
24 Clarus	0			24,500	301,652	12.312	-24,500	301,652
65 Goldman	200	2,491	12.455	30,300	385,452	12.721	-30,100	382,961
62 Haywood	14,100	176,187	12.496	51,525	635,696	12.338	-37,425	459,509
99 Jitney	680,400	8,492,196	12.481	719,800	8,969,736	12.461	-39,400	477,540
53 Morgan Stanley	59,683	744,092	12.467	104,828	1,310,897	12.505	-45,145	566,805
83 Mackie	0			49,000	621,019	12.674	-49,000	621,019
85 Scotia	1,599,088	19,932,872	12.465	1,665,922	20,739,515	12.449	-66,834	806,643
33 Canaccord	8,172	102,365	12.526	87,931	1,095,935	12.464	-79,759	993,570
13 Instinet	386,444	4,836,218	12.515	508,600	6,368,389	12.521	-122,156	1,532,171
2 RBC	2,055,240	25,641,271	12.476	2,258,858	28,237,488	12.501	-203,618	2,596,217
1 Anonymous	4,723,916	58,940,159	12.477	4,967,961	61,886,311	12.457	-244,045	2,946,152
124 Questrade	681,360	8,503,765	12.481	964,153	11,964,288	12.409	-282,793	3,460,523
39 Merrill Lynch	1,477,193	18,328,013	12.407	1,803,557	22,538,714	12.497	-326,364	4,210,701
7 TD Sec	5,153,161	64,361,327	12.49	5,555,164	69,337,015	12.482	-402,003	4,975,688
9 BMO Nesbitt	773,363	9,641,341	12.467	1,307,124	16,405,570	12.551	-533,761	6,764,229
TOTAL	30,528,239	380,955,797	12.479	30,528,239	380,955,797	12.479	0	0

Aphria Introduces First Cannabis Strains to be Produced in Europe with Export to Danish Partner Schroll Medical

Canada NewsWire

LEAMINGTON, ON, Feb. 1, 2019

LEAMINGTON, ON, Feb. 1, 2019 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA andNYSE: APHA) has completed its first transfer of plant cuttings from four of the Company's cannabis strains to Denmark-based Schroll Medical ("Schroll"), as part of the Company's previously announced Strategic Partnership (the "Partnership") with Schroll. The shipment was completed under permits issued by the relevant health authorities, including an export permit from Health Canada, an import permit from the Danish Medicines Agency and a phytosanitary certificate from the Canadian Food Inspection Agency.

"We are pleased to introduce the first four Aphria strains to be produced in Europe, through our strategic alliance with Schroll," said Hendrik Knopp, Managing Director of Aphria Germany, who is overseeing the Partnership on behalf of Aphria and Schroll. "This marks another important milestone for Aphria as we extend our leadership position in the European market, and it gives me joy to be able to say today that we literally have a good thing growing in Europe."
As previously announced, Aphria will handle the worldwide distribution of medical cannabis produced by the Partnership, which is anticipated to be made available to markets across Europe as medical cannabis markets develop. Aphria plans to complete a second shipment of additional strains to Schroll in the coming months.
We Have A Good Thing Growing
About Aphria
Aphria is a leading global cannabis company driven by an unrelenting commitment to our people, product quality and innovation. Headquartered in Leamington, Ontario – the greenhouse capital of Canada – Aphria has been setting the standard for the low-cost production of safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible. Focusing on untapped opportunities and backed by the latest technologies, Aphria is committed to bringing breakthrough innovation to the global cannabis market. The Company's portfolio of brands is grounded in expertly-researched consumer insights designed to meet the needs of every consumer segment. Rooted in our founders' multi-generational expertise in commercial agriculture, Aphria drives sustainable long-term shareholder value through a diversified approach to innovation, strategic partnerships and global expansion, with a presence in more than 10 countries across 5 continents.
For more information, visit: aphria.ca